vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $379.6M, roughly 1.3× DIVERSIFIED HEALTHCARE TRUST). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -5.6%, a 12.4% gap on every dollar of revenue. On growth, DIVERSIFIED HEALTHCARE TRUST posted the faster year-over-year revenue change (-0.0% vs -1.7%). Over the past eight quarters, DIVERSIFIED HEALTHCARE TRUST's revenue compounded faster (1.2% CAGR vs -0.1%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

DHC vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.3× larger
MD
$493.8M
$379.6M
DHC
Growing faster (revenue YoY)
DHC
DHC
+1.7% gap
DHC
-0.0%
-1.7%
MD
Higher net margin
MD
MD
12.4% more per $
MD
6.8%
-5.6%
DHC
Faster 2-yr revenue CAGR
DHC
DHC
Annualised
DHC
1.2%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DHC
DHC
MD
MD
Revenue
$379.6M
$493.8M
Net Profit
$-21.2M
$33.7M
Gross Margin
Operating Margin
-12.6%
9.9%
Net Margin
-5.6%
6.8%
Revenue YoY
-0.0%
-1.7%
Net Profit YoY
75.7%
10.5%
EPS (diluted)
$-0.09
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
MD
MD
Q4 25
$379.6M
$493.8M
Q3 25
$388.7M
$492.9M
Q2 25
$382.7M
$468.8M
Q1 25
$386.9M
$458.4M
Q4 24
$379.6M
$502.4M
Q3 24
$373.6M
$511.2M
Q2 24
$371.4M
$504.3M
Q1 24
$370.8M
$495.1M
Net Profit
DHC
DHC
MD
MD
Q4 25
$-21.2M
$33.7M
Q3 25
$-164.0M
$71.7M
Q2 25
$-91.6M
$39.3M
Q1 25
$-9.0M
$20.7M
Q4 24
$-87.4M
$30.5M
Q3 24
$-98.7M
$19.4M
Q2 24
$-97.9M
$-153.0M
Q1 24
$-86.3M
$4.0M
Operating Margin
DHC
DHC
MD
MD
Q4 25
-12.6%
9.9%
Q3 25
-43.4%
13.8%
Q2 25
-24.5%
12.8%
Q1 25
-2.7%
7.0%
Q4 24
-26.1%
7.8%
Q3 24
-26.5%
6.6%
Q2 24
-23.0%
-31.3%
Q1 24
-23.7%
3.2%
Net Margin
DHC
DHC
MD
MD
Q4 25
-5.6%
6.8%
Q3 25
-42.2%
14.5%
Q2 25
-23.9%
8.4%
Q1 25
-2.3%
4.5%
Q4 24
-23.0%
6.1%
Q3 24
-26.4%
3.8%
Q2 24
-26.3%
-30.3%
Q1 24
-23.3%
0.8%
EPS (diluted)
DHC
DHC
MD
MD
Q4 25
$-0.09
$0.40
Q3 25
$-0.68
$0.84
Q2 25
$-0.38
$0.46
Q1 25
$-0.04
$0.24
Q4 24
$-0.37
$0.37
Q3 24
$-0.41
$0.23
Q2 24
$-0.41
$-1.84
Q1 24
$-0.36
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
MD
MD
Cash + ST InvestmentsLiquidity on hand
$105.4M
$375.2M
Total DebtLower is stronger
$2.4B
$570.5M
Stockholders' EquityBook value
$1.7B
$865.9M
Total Assets
$4.4B
$2.2B
Debt / EquityLower = less leverage
1.47×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
MD
MD
Q4 25
$105.4M
$375.2M
Q3 25
$201.4M
$340.1M
Q2 25
$141.8M
$224.7M
Q1 25
$302.6M
$99.0M
Q4 24
$144.6M
$229.9M
Q3 24
$256.5M
$103.8M
Q2 24
$265.6M
$19.4M
Q1 24
$207.1M
$8.0M
Total Debt
DHC
DHC
MD
MD
Q4 25
$2.4B
$570.5M
Q3 25
$577.2M
Q2 25
$583.9M
Q1 25
$590.5M
Q4 24
$3.1B
$597.1M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
MD
MD
Q4 25
$1.7B
$865.9M
Q3 25
$1.7B
$890.7M
Q2 25
$1.9B
$833.8M
Q1 25
$1.9B
$789.2M
Q4 24
$2.0B
$764.9M
Q3 24
$2.0B
$732.5M
Q2 24
$2.1B
$706.5M
Q1 24
$2.2B
$856.2M
Total Assets
DHC
DHC
MD
MD
Q4 25
$4.4B
$2.2B
Q3 25
$4.7B
$2.2B
Q2 25
$4.8B
$2.1B
Q1 25
$5.0B
$2.0B
Q4 24
$5.1B
$2.2B
Q3 24
$5.3B
$2.1B
Q2 24
$5.3B
$2.0B
Q1 24
$5.3B
$2.2B
Debt / Equity
DHC
DHC
MD
MD
Q4 25
1.47×
0.66×
Q3 25
0.65×
Q2 25
0.70×
Q1 25
0.75×
Q4 24
1.56×
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
MD
MD
Operating Cash FlowLast quarter
$-19.6M
$114.1M
Free Cash FlowOCF − Capex
$-166.4M
FCF MarginFCF / Revenue
-43.8%
Capex IntensityCapex / Revenue
38.7%
Cash ConversionOCF / Net Profit
3.39×
TTM Free Cash FlowTrailing 4 quarters
$-280.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
MD
MD
Q4 25
$-19.6M
$114.1M
Q3 25
$-49.3M
$137.3M
Q2 25
$53.0M
$137.2M
Q1 25
$-3.2M
$-117.5M
Q4 24
$112.2M
$133.0M
Q3 24
$21.1M
$91.8M
Q2 24
$44.3M
$107.0M
Q1 24
$28.6M
$-125.2M
Free Cash Flow
DHC
DHC
MD
MD
Q4 25
$-166.4M
Q3 25
$-89.8M
Q2 25
$18.8M
Q1 25
$-42.9M
Q4 24
$-89.5M
Q3 24
$-26.1M
Q2 24
$3.3M
Q1 24
$-18.1M
FCF Margin
DHC
DHC
MD
MD
Q4 25
-43.8%
Q3 25
-23.1%
Q2 25
4.9%
Q1 25
-11.1%
Q4 24
-23.6%
Q3 24
-7.0%
Q2 24
0.9%
Q1 24
-4.9%
Capex Intensity
DHC
DHC
MD
MD
Q4 25
38.7%
Q3 25
10.4%
Q2 25
8.9%
Q1 25
10.2%
Q4 24
53.1%
Q3 24
12.6%
Q2 24
11.0%
Q1 24
12.6%
Cash Conversion
DHC
DHC
MD
MD
Q4 25
3.39×
Q3 25
1.91×
Q2 25
3.49×
Q1 25
-5.66×
Q4 24
4.36×
Q3 24
4.72×
Q2 24
Q1 24
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons